"We need to move to a system where new drugs are priced as close to the cost of production as possible - and where innovation is paid for and rewarded separatel

"We need to move to a system where new drugs are priced as close to the cost of production as possible - and where innovation is paid for and rewarded separately. We need innovation and affordable access." - A challenging pricing problem that needs to be solved.